NECFA
IDXX icon

New England Capital Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

New England Capital Financial Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11
Closed -$5.5K – 415
2023
Q1 		$5.5K Buy
+11
New +$5.26K ﹤0.01% 286

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

New England Capital Financial Advisors's IDXX Position: Q2 2023 in Review

New England Capital Financial Advisors sold out of Idexx Laboratories (IDXX) in Q2 2023, closing a stake of 11 shares — an estimated $5.5K sold.

New England Capital Financial Advisors first reported a position in IDXX in Q1 2023 and held it in 1 quarter. The position peaked at $5.5K in Q1 2023. 1,068 funds tracked by Wall St. Rank hold IDXX as of Q2 2023.

  • New England Capital Financial Advisors reported no remaining Idexx Laboratories position as of Q2 2023 after selling out during the quarter.
  • New England Capital Financial Advisors sold 11 Idexx Laboratories shares in Q2 2023, an estimated $5.5K.
  • New England Capital Financial Advisors first reported a position in Idexx Laboratories in Q1 2023 and held it in 1 quarter.
  • New England Capital Financial Advisors's Idexx Laboratories position peaked at $5.5K in Q1 2023.
  • 1,068 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2023.

Based on New England Capital Financial Advisors's 13F filing for Q2 2023, filed 2 Aug 2023.